Thoracic Surgery Devices Global Market Report 2024

The thoracic surgery devices market size has grown rapidly in recent years. It will grow from $8.07 billion in 2023 to $8.89 billion in 2024 at a compound annual growth rate (CAGR) of 10.1%. The expansion observed in the historical period can be ascribed to progress in surgical methodologies, a growing aging population coupled with the prevalence of thoracic diseases, rising surgical caseloads, development in healthcare infrastructure, and initiatives focused on training and education.

The thoracic surgery devices market size is expected to see strong growth in the next few years. It will grow to $12.3 billion in 2028 at a compound annual growth rate (CAGR) of 8.5%. The forecasted growth in the upcoming period can be credited to the integration of robotics and AI, adoption of patient-centric approaches, the provision of customized implant solutions, the implementation of telemedicine and remote surgery, and the adoption of value-based healthcare models. Notable trends anticipated in the forecast period encompass global collaborations in healthcare, technological advancements in medical devices, progress in imaging technology, the increasing utilization of telemedicine, remote surgical support, and the rise in ambulatory surgical centers (ASCs).

The anticipated growth in the thoracic surgery device market is driven by the increasing prevalence of thoracic diseases. These diseases affect various organs and structures within the thoracic cavity, including the heart, lungs, esophagus, trachea, diaphragm, and major blood vessels. Thoracic surgery devices play a crucial role in assisting surgeons during chest cavity procedures, ensuring precision, effectiveness, and safety. For instance, in 2023, chronic obstructive pulmonary disease (COPD) constituted 3.6% of the total disease burden and represented 50% of the total burden of respiratory conditions in Australia, according to the Australian Institute of Health and Welfare. Thus, the rising prevalence of thoracic diseases is a key driver for the growth of the thoracic surgery device market.

The expected increase in cases of lung cancer is set to propel the growth of the thoracic surgery device market. Lung cancer, often linked to tobacco exposure, is characterized by uncontrolled cell proliferation in lung cells. Thoracic surgery devices are essential in the treatment of lung cancer, facilitating precise procedures such as tumor removal, biopsies, and lung resections to improve patient outcomes and minimize invasiveness. In January 2023, the American Cancer Society reported that lung cancer accounted for approximately 20% of all cancer-related deaths in the United States. The estimate for 2023 suggests 238,340 new cases, with 127,070 resulting in fatalities. Additionally, the Centers for Disease Control and Prevention reported 197,453 new cases of lung and bronchial cancer in the United States in 2020. Thus, the growing incidence of lung cancer is a significant factor driving the growth of the thoracic surgery device market.

A shortage of skilled professionals is expected to impede the growth of the thoracic surgery device market. The scarcity of proficient thoracic surgeons hinders market expansion by limiting the seamless adoption and utilization of advanced technologies. For instance, ReactDx reported that by 2035, there is an anticipated 121% surge in cardiothoracic surgeries, with a decline in practicing surgeons to 3,000 by 2030, handling a 61% increase in cases. Therefore, the lack of skilled professionals poses a constraint on the growth of the thoracic surgery device market.

Prominent companies in the thoracic surgery devices market are actively creating cutting-edge products incorporating advanced technologies, such as 3D-printed airway stents. These innovations aim to deliver tailored, precise, and durable support to compromised airways. The 3D-printed bioresorbable airway stent is a medical device crafted using a digital 3D model and produced layer by layer through a DLP printer. For example, in February 2021, ETH Zurich, a Swiss-based university, unveiled 3D-printed bioresorbable airway stents customized to patients, gradually dissolving after implantation. Manufactured using digital light processing (DLP) and specific light-sensitive resins, these stents are constructed with bioresorbable materials and 3D-printing technology. They are designed to match an individual's specific airway anatomy, offering personalized support without the necessity for invasive removal procedures.

In May 2022, Medtronic PLC, a leading US-based medical devices company, completed the acquisition of Intersect ENT for an undisclosed amount. This strategic move enables Medtronic to broaden its portfolio by gaining access to Intersect ENT's innovative bioabsorbable steroid-eluting sinus implant product lines. Intersect ENT, a US-based medical equipment manufacturing company, specializes in delivering innovative and clinically meaningful thoracic devices and therapies to healthcare professionals and patients.

Major companies operating in the thoracic surgery devices market report are Cardinal Health, Medtronic PLC, Danaher Corporation, Becton, Dickinson and Company, Stryker Corporation, B. Braun Melsungen AG, Olympus Corporation, Intuitive Surgical, Getinge AB, Teleflex Inc., Cook Group Incorporated, Richard Wolf GmbH, Scanlan International, OmniGuide Holdings Inc., KLS Martin Group, Sklar Surgical Instruments, ATMOS MedizinTechnik GmbH & Co. KG, Medela Healthcare, Dextera Surgical Inc., Biolitec AG, Johnson & Johnson Private Limited, Cardio medical GmbH, Grena Ltd., LivaNova PLC, Sinapi Biomedical.

North America was the largest region in the thoracic surgery devices market in 2023. The regions covered in the thoracic surgery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the thoracic surgery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Thoracic surgery devices encompass a diverse array of specialized instruments and equipment crafted for utilization in surgeries concerning the thorax, the region that encompasses vital structures such as the lungs, heart, and esophagus within the chest area. These devices are meticulously designed to afford surgeons precise control and enhanced visualization during surgical interventions, thereby minimizing the risk of complications and elevating overall patient outcomes.

The primary product categories within thoracic surgery devices include forceps, graspers, clamps and staplers, scissors, spreaders, needle holders, and various other instruments. Forceps, characterized as handheld and hinged tools, find application in medical and surgical procedures, serving functions such as grasping, holding, and applying traction, particularly in delicate surgical contexts. Diverse surgery types, including lobectomy, wedge resection, pneumonectomy, and others, make use of these devices, with end-users spanning hospitals, ambulatory surgical centers, and other medical settings.

The thoracic surgery devices market research report is one of a series of new reports that provides thoracic surgery devices market statistics, including thoracic surgery devices industry global market size, regional shares, competitors with a thoracic surgery devices market share, detailed thoracic surgery devices market segments, market trends and opportunities, and any further data you may need to thrive in the thoracic surgery devices industry. This esophageal catheter market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The thoracic surgery devices market includes revenues earned by entities by providing products such as thoracoscope, thoracic drainage systems, thoracic retractors and tissue sampling devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.